“Nanotechnology-Driven Bioavailability Enhancement: A Critical Review of BCS Class II and IV Drugs”. Journal of Drug Discovery and Health Sciences 3, no. 03 (September 16, 2026): 63–71. Accessed September 17, 2026. https://jddhs.com/index.php/jddhs/article/view/146.